Charles Conover - Net Worth and Insider Trading
Charles Conover Net Worth
The estimated net worth of Charles Conover is at least $4,863 dollars as of 2024-11-10. Charles Conover is the SVP, R&D Program Management of Enzon Pharmaceuticals Inc and owns about 57,213 shares of Enzon Pharmaceuticals Inc (ENZN) stock worth over $4,863. Details can be seen in Charles Conover's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Charles Conover has not made any transactions after 2012-06-05 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Charles Conover
Charles Conover Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Charles Conover owns 1 companies in total, including Enzon Pharmaceuticals Inc (ENZN) .
Click here to see the complete history of Charles Conover’s form 4 insider trades.
Insider Ownership Summary of Charles Conover
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| ENZN | Enzon Pharmaceuticals Inc | 2012-06-05 | SVP & R&D Program Management |
Charles Conover Latest Holdings Summary
Charles Conover currently owns a total of 1 stock. Charles Conover owns 57,213 shares of Enzon Pharmaceuticals Inc (ENZN) as of June 5, 2012, with a value of $4,863.
Latest Holdings of Charles Conover
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| ENZN | Enzon Pharmaceuticals Inc | 2012-06-05 | 57,213 | 0.09 | 4,863 |
Holding Weightings of Charles Conover
Charles Conover Form 4 Trading Tracker
According to the SEC Form 4 filings, Charles Conover has made a total of 0 transactions in Enzon Pharmaceuticals Inc (ENZN) over the past 5 years. The most-recent trade in Enzon Pharmaceuticals Inc is the sale of 25,000 shares on June 5, 2012, which brought Charles Conover around $169,500.
Insider Trading History of Charles Conover
- 1
Charles Conover Trading Performance
Charles Conover Ownership Network
Ownership Network List of Charles Conover
Ownership Network Relation of Charles Conover
Charles Conover Owned Company Details
What does Enzon Pharmaceuticals Inc do?
Who are the key executives at Enzon Pharmaceuticals Inc?
Charles Conover is the SVP & R&D Program Management of Enzon Pharmaceuticals Inc. Other key executives at Enzon Pharmaceuticals Inc include other: See Footnote 1 Family Fund Couchman , other: See explanation of responses Brian James Harper , and other: See explanation of responses Harper Asset Management Llc .
Enzon Pharmaceuticals Inc (ENZN) Insider Trades Summary
Over the past 18 months, Charles Conover made no insider transaction in Enzon Pharmaceuticals Inc (ENZN). Other recent insider transactions involving Enzon Pharmaceuticals Inc (ENZN) include a net purchase of 99,550 shares made by Randolph C Read ,
In summary, during the past 3 months, insiders sold 0 shares of Enzon Pharmaceuticals Inc (ENZN) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Enzon Pharmaceuticals Inc (ENZN) were sold and 99,550 shares were bought by its insiders, resulting in a net purchase of 99,550 shares.
Enzon Pharmaceuticals Inc (ENZN)'s detailed insider trading history can be found in Insider Trading Tracker table.
Enzon Pharmaceuticals Inc Insider Transactions
Charles Conover Mailing Address
Above is the net worth, insider trading, and ownership report for Charles Conover. You might contact Charles Conover via mailing address: 20 Kingsbridge Road, Piscataway Nj 08854.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
